EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

D90 and D2CC Dose in Vaginal CTV as Dosimetric Predictors of Late Vaginal Side Effects in Postoperative Vaginal Modern Brachytherapy (Interventional Radiotherapy) After External Beam Irradiation in Endometrial Cancer

Yao Qiang, Faegheh Noorian iD, Rosa Abellana iD, Clara Baltrons, Valentina Lancellotta iD, Luca Tagliaferri, Jaume Ordi, Angeles Rovirosa iD

Cancers · 21.07.2026 · 18 (14) · 2350

DOI: 10.3390/cancers18142350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 21.07.2026. Verfasst von Yao Qiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fonaments Clínics Department, Faculty of Medicine, Universitat de Barcelona, 08036 Barcelona, Spain. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: To evaluate clinical and dosimetric predictors of vaginal toxicity in patients treated with vaginal-cuff brachytherapy (VCB), with or without external beam radiotherapy (EBRT), and assess the impact of different prescription and optimization strategies on dose–volume parameters.

Methods

We retrospectively analyzed 217 patients treated with EBRT combined with VCB (n = 120) or VCB alone (n = 97). In VCB three prescription and optimization strategies (volume-based, graphical optimization, and 5 mm distance-based prescription) were compared to determine differences in dose–volume parameters. In patients who developed late vaginal side effects, the dosimetric parameters were evaluated using descriptive statistics and Cox regression modeling. Kaplan–Meier analysis was performed to assess time to toxicity.

Results

In the EBRT+VCB cohort, 34/120 patients (28.3%) developed grade 1–2 vaginal toxicity compared to 35/97 (36%) in the VCB alone cohort. In the EBRT+VCB group, patients with toxicity received a higher D90 per fraction and higher vaginal D2cc. In multivariable analysis, vaginal D2cc (HR = 1.60, 95% CI = 1.01–2.54, p = 0.045) and CTV-DVH (HR = 0.77, 95% CI = 0.61–0.97, p = 0.027) were independently associated with toxicity. No significant dose–toxicity associations were observed in the VCB-alone cohort. Most events occurred within 48 months in both groups. Comparison of prescription strategies showed systematic differences in target and organ-at-risk dose–volume parameters, including vaginal D2cc. The 5 mm distance-based prescription consistently resulted in higher D90, D100, EQD2, and vaginal D2cc values.

Conclusions

In patients receiving EBRT combined with VCB, both vaginal D2cc and target dose distribution were associated with vaginal toxicity. The prescription and optimization strategy significantly influenced dose–volume parameters. Planning methodology and dosimetric aspects should be considered when interpreting dose–toxicity relationships in vaginal brachytherapy.

Schlagwörter

Stichwörter der Autor:innen

late vaginal secondary effectspostoperative endometrial cancerprescription and optimization strategiesvaginal-cuff brachytherapy

Autor:innen und Institutionen

  • Fonaments Clínics Department, Faculty of Medicine, Universitat de Barcelona, 08036 Barcelona, Spain.
  • Radiation Oncology Department, Hospital Clínic Universitat de Barcelona, 08036 Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Casanovas 153, 08036 Barcelona, Spain.
  • Dipartimento di Diagnostica per Immagini, U.O.C. Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Radioterapia Oncologica ed Ematologia, Università Cattolica del Sacro Cuore, 00168 Rome, I…
  • Barcelona Institute for Global Health, 08036 Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.

ORCID-Profile: Faegheh Noorian, Rosa Abellana, Valentina Lancellotta, Angeles Rovirosa

Zitieren

APA

Qiang, Y., Noorian, F., Abellana, R., Baltrons, C., Lancellotta, V., Tagliaferri, L., Ordi, J., & Rovirosa, A. (2026). D90 and D2CC Dose in Vaginal CTV as Dosimetric Predictors of Late Vaginal Side Effects in Postoperative Vaginal Modern Brachytherapy (Interventional Radiotherapy) After External Beam Irradiation in Endometrial Cancer. Cancers, 18(14), 2350. https://doi.org/10.3390/cancers18142350

Vancouver

Qiang Y, Noorian F, Abellana R, Baltrons C, Lancellotta V, Tagliaferri L, et al. D90 and D2CC Dose in Vaginal CTV as Dosimetric Predictors of Late Vaginal Side Effects in Postoperative Vaginal Modern Brachytherapy (Interventional Radiotherapy) After External Beam Irradiation in Endometrial Cancer. Cancers. 2026;18(14):2350. doi:10.3390/cancers18142350

BibTeX
@article{Qiang2026,
  author = {Qiang, Yao and Noorian, Faegheh and Abellana, Rosa and Baltrons, Clara and Lancellotta, Valentina and Tagliaferri, Luca and Ordi, Jaume and Rovirosa, Angeles},
  title = {D90 and D2CC Dose in Vaginal CTV as Dosimetric Predictors of Late Vaginal Side Effects in Postoperative Vaginal Modern Brachytherapy (Interventional Radiotherapy) After External Beam Irradiation in Endometrial Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {14},
  pages = {2350},
  doi = {10.3390/cancers18142350}
}
Kostenlos starten →